Nature

Nature, first published on 4 November 1869, is ranked the world s most cited interdisciplinary scientific journal by the Science Edition of the 2010 Journal Citation Reports. Most scientific journals are now highly specialized, and Nature is among the few journals (the other weekly journals Science and Proceedings of the National Academy of Sciences are also prominent examples) that still publish original research articles across a wide range of scientific fields. There are many fields of scientific research in which important new advances and original research are published as either articles or letters in Nature. Research scientists are the primary audience for the journal, but summaries and accompanying articles are intended to make many of the most important papers understandable to scientists in other fields and the educated general public. Towards the front of each issue are editorials, news and feature articles on issues of general interest to scientists, including current affairs, science funding, business, scientific ethics and research breakthroughs. There are also sections on books and arts.

Publisher
Nature Publishing Group
Country
United Kingdom
History
1869-present
Website
http://www.nature.com/nature/index.html
Impact factor
36.101 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Neuroscience

Perfect balance: How the brain fine-tunes its sensitivity

A sensitive perception of the environment is crucial for guiding our behavior. However, an overly sensitive response of the brain's neural circuits to stimuli can lead to neurodevelopmental disorders such as epilepsy. University ...

Neuroscience

Investigators identify a group of cells involved in working memory

Cedars-Sinai investigators have discovered how brain cells responsible for working memory—the type required to remember a phone number long enough to dial it—coordinate intentional focus and short-term storage of information. ...

Medications

Common HIV treatments may aid Alzheimer's disease patients

Alzheimer's disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly 13 million by 2050, the lack of meaningful therapies represents a major unmet medical need. Scientists ...

Oncology & Cancer

Q&A: When will patients see personalized cancer vaccines?

Catherine Wu has been a pioneer in a promising approach to fight cancer: vaccines that target specific immune-stimulating molecules, known as immunogenic peptides, generated by the distinct genetic mutations of any individual ...

Oncology & Cancer

Researchers identify protein that controls CAR T cell longevity

CAR T cell therapy has revolutionized the way certain types of cancer are treated, and the longer those CAR T cells live in a patient's body, the more effectively they respond to cancer. Now, in a new study, researchers at ...

page 1 from 17